Nabi Biopharmaceuticals is a biopharmaceutical company focused on the development of products in the areas of nicotine addiction and infectious disease. The Company’s products in development are Nicotine Conjugate Vaccine (NicVAX) and Pentavalent S.aureus Vaccine (PentaStaph). NicVAX is an investigational vaccine. NicVAX is designed to stimulate the immune system to produce highly specific antibodies that bind to nicotine. PentaStaph is an investigational vaccine based on technology that it has licensed on an basis from the National Institutes of Health (NIH).
(Source: 10-K) – less–ZoomInfo